Identifying and managing patients with hyperlipidemia

American Journal of Managed Care

Volumn 3, Issue 8, 1997, Pages 1211-1219

  Clark, Amy B ^a   Holt, James M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; EDUCATION; FEMALE; HEALTH BEHAVIOR; HUMAN; HYPERLIPIDEMIA; MALE; MEDICAL EDUCATION; PRACTICE GUIDELINE; RISK FACTOR; UNITED STATES;

ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; EDUCATION, MEDICAL, CONTINUING; EDUCATION, PHARMACY; FEMALE; HEALTH BEHAVIOR; HUMANS; HYPERLIPIDEMIAS; MALE; PRACTICE GUIDELINES; RISK FACTORS; UNITED STATES;

EID: 0031203305     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1329-1345.
2. The Lipid Research Clinics Population Studies Data Book. Vol. 1. Bethesda, MD: U.S. Department of Health and Human Services, 1980. Publication NIH-80-1527.
3. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
4. Steinberg D, Witzum JL. Lipoproteins and atherogenesis: Current concepts. JAMA 1990;264:3047-3052.
5. Havel RJ, Rapaport E. Management of primary hyperlipidemia. N Engl J Med 1995;332:1491-1498.
6. Stone NG. Secondary causes of hyperlipidemia. Med Clin North Am 1993;78:117-141.
7. Miller M, Vogel RA. The Practice of Coronary Disease Prevention. Williams & Wilkins, Baltimore, MD;1996:76-78.
8. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, I: Reductions in incidence of coronary heart disease. JAMA 1984;251:351-364.
9. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, II: The relationship of reduction in incidence of heart disease to cholesterol lowering. JAMA 1984;251:365-374.
10. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA 1975;231:360-381.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
12. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl J Med 1996;335: 1001-1009.
13. Frick MH, Elo O, Haapa K, et al. Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. New Engl J Med 1987;317:1237-1245.
14. Oliver MF, Heady JA, Morris JN, Cooper J. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978;40:1069-1118.
15. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow-up from the nurses' health study. New Engl J Med 1991;325:756-762.
16. Writing Group for PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease in postmenopausal women: The postmenopausal estrogen/progestin trial. JAMA 1995;273:199-208.
17. Keli SO, Feskens EJM, Kromhout D. Fish consumption and risk of stroke. The Zutphen study. Stroke 1994;25:328-332.
18. Burr ML, Gilbert JF, Holliday RM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989;2:757-761.
19. Gazian JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. New Engl J Med 1993;329:1829-1834.
20. Health United States 1994. Hyattsville, MD: U.S. Department of Health and Human Services, 1995. DHHS publication no. (PHS)95-1232.
21. 1996 Drug Topics Redbook - Pharmacy's Fundamental Reference and the March 1997 Update. Montvale, NJ: Medical Economics Company;1996.
22. Pederson TR, Kjekshus J, Berg K, et al. Cholesterol lowering and the use of healthcare resources: Results of the Scandinavian Simvastatin Survival Study. Circulation 1996;93:1796-1802.